Human CX3CL1/Fractalkine Quantikine ELISA Kit
| Name | Human CX3CL1/Fractalkine Quantikine ELISA Kit |
|---|---|
| Supplier | R&D Systems |
| Catalog | DCX310 |
| Category | ELISA Kit |
| Prices | $509.00 |
| Sizes | 1 kit |
| Assay Type | Solid Phase Sandwich ELISA |
| Sample Type | Cell Culture Supernates (100 uL), Serum (100 uL), EDTA Plasma (100 uL), Heparin Plasma (100 uL), Saliva (50 uL), Urine (50 uL), Human Milk (100 uL) |
| Sensitivity | 0.072 ng/mL |
| Range | 0.2 - 10 ng/mL (Cell Culture Supernates, Serum, EDTA Plasma, Heparin Plasma, Saliva, Urine, Human Milk) |
| Format | 96-well strip plate |
| Applications | ELISA |
| Species Reactivities | Human |
| Description | The Quantikine Human Fractalkine immunoassay is a 4.5 hour solid phase ELISA designed to measure Fractalkine in cell culture supernates, serum, plasma, saliva, urine, and human milk |
| Gene | CX3CL1 |
| Supplier Page | Shop |
Product images
Product References
Altered Monocyte and Endothelial Cell Adhesion Molecule Expression Is Linked to - Altered Monocyte and Endothelial Cell Adhesion Molecule Expression Is Linked to
Kulkarni M, Bowman E, Gabriel J, Amburgy T, Mayne E, Zidar DA, Maierhofer C, Turner AN, Bazan JA, Koletar SL, Lederman MM, Sieg SF, Funderburg NT. Open Forum Infect Dis. 2016 Oct 15;3(4):ofw224.
Assessment of the Role of Metabolic Determinants on the Relationship between - Assessment of the Role of Metabolic Determinants on the Relationship between
Galgani JE, Gomez C, Mizgier ML, Gutierrez J, Santos JL, Olmos P, Mari A. PLoS One. 2016 Dec 21;11(12):e0168352.
Fractalkine-CX3CR1-dependent recruitment and retention of human CD1c+ myeloid - Fractalkine-CX3CR1-dependent recruitment and retention of human CD1c+ myeloid
Kassianos AJ, Wang X, Sampangi S, Afrin S, Wilkinson R, Healy H. Kidney Int. 2015 Jun;87(6):1153-63.
T lymphocytes and fractalkine contribute to myocardial ischemia/reperfusion - T lymphocytes and fractalkine contribute to myocardial ischemia/reperfusion
Boag SE, Das R, Shmeleva EV, Bagnall A, Egred M, Howard N, Bennaceur K, Zaman A, Keavney B, Spyridopoulos I. J Clin Invest. 2015 Aug 3;125(8):3063-76.
Identification of the chemokine CX3CL1 as a new regulator of malignant cell - Identification of the chemokine CX3CL1 as a new regulator of malignant cell
Gaudin F, Nasreddine S, Donnadieu AC, Emilie D, Combadiere C, Prevot S, Machelon V, Balabanian K. PLoS One. 2011;6(7):e21546.
Fractalkine is an independent predictor of mortality in patients with advanced - Fractalkine is an independent predictor of mortality in patients with advanced
Richter B, Koller L, Hohensinner PJ, Rychli K, Zorn G, Goliasch G, Berger R, Mortl D, Maurer G, Huber K, Pacher R, Wojta J, Hulsmann M, Niessner A. Thromb Haemost. 2012 Dec;108(6):1220-7.
Altered expression of CX3CL1 in patients with epilepsy and in a rat model. - Altered expression of CX3CL1 in patients with epilepsy and in a rat model.
Xu Y, Zeng K, Han Y, Wang L, Chen D, Xi Z, Wang H, Wang X, Chen G. Am J Pathol. 2012 May;180(5):1950-62.
Systemic biomarkers of inflammation and haemostasis in patients with chronic - Systemic biomarkers of inflammation and haemostasis in patients with chronic
Rodland EK, Ueland T, Bjornsen S, Sagen EL, Dahl CP, Naalsund A, Mollnes TE, Brosstad FR, Muller F, Aukrust P, Froland SS. BMC Infect Dis. 2012 Jun 25;12:144.
Early detection of malignant pleural mesothelioma in asbestos-exposed individuals - Early detection of malignant pleural mesothelioma in asbestos-exposed individuals
Ostroff RM, Mehan MR, Stewart A, Ayers D, Brody EN, Williams SA, Levin S, Black B, Harbut M, Carbone M, Goparaju C, Pass HI. PLoS One. 2012;7(10):e46091.
Fractalkine is expressed in early and advanced atherosclerotic lesions and - Fractalkine is expressed in early and advanced atherosclerotic lesions and
Stolla M, Pelisek J, von Bruhl ML, Schafer A, Barocke V, Heider P, Lorenz M, Tirniceriu A, Steinhart A, Bauersachs J, Bray PF, Massberg S, Schulz C. PLoS One. 2012;7(8):e43572.